Muscle-relaxing agent as drug for the treatment of bronchoconstriction caused by asthma and COPD
The innovation presented here provides a substance and application there of which is suitable to be utilized as drug both in human and in veterinary medicine to counteract bronchoconstriction (narrowing of the airways) and its spasmodic form, bronchial spasm, due to the muscle-relaxing properties of the substance.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Magnetic tornado is stirring up the haze at Jupiter’s poles
Unusual magnetically driven vortices may be generating Earth-size concentrations of hydrocarbon haze. While Jupiter’s Great Red Spot has been a constant feature of the planet for centuries, University of California,…
Cause of common cancer immunotherapy side effect s
New insights into how checkpoint inhibitors affect the immune system could improve cancer treatment. A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation…
New tool makes quick health, environmental monitoring possible
University of Wisconsin–Madison biochemists have developed a new, efficient method that may give first responders, environmental monitoring groups, or even you, the ability to quickly detect harmful and health-relevant substances…